Research output per year
Research output per year
Fingerprint
Dive into the research topics where Wolfgang Brückl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Analysis of baseline interstitial lung abnormality on the risk of checkpoint inhibitor-related pneumonitis and survival in advanced non-small cell lung cancer patients treated with first-line PD-1/ PD-L1 inhibitors
Li, Y., Liang, S., Du, Y., Yao, J., Jiang, Y., Lu, W., Wu, Q., Yamaguchi, F., Jakopovic, M., Brueckl, W. M. (Co-author), Wang, D., Zhang, F., Wang, Q., Lv, T. & Zhan, P., 31 Mar 2025, In: TRANSLATIONAL LUNG CANCER RESEARCH. 14, 3, 24 p.Research output: Contribution to journal › Original Article › peer-review
Open Access20 Citations (Web of Science) -
To be or low TMB (tumor mutational burden)
Falk, M., Tiemann, M., Ficker, J. H. (Co-author) & Brueckl, W. M. (Last author), 28 Feb 2025, In: Translational Cancer Research. 14, 2, p. 667-669 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Trastuzumab rezetecan, a new antibody-drug conjugate in HER2-mutated NSCLC
Brueckl, W. (First author), Apr 2025, In: LANCET ONCOL. 26, 4, p. 401-403 3 p.Research output: Contribution to journal › Short comment / notes › peer-review
-
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315): a randomised, international, multicentre, double-blind, placebo-controlled trial
Griesinger, F., Sebastian, M., Brueckl, W. M. (Co-author), Hummel, H.-D., Jaeschke, B., Kern, J., Wesseler, C., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Groth, A., Weichert, W., Dörfel, S., Petersen, V., Schröder, J., Wilke, J., Eberhardt, W. E. E., Thomas, M. & CRISP Registry Group, 2 Mar 2024, In: JTO Clinical and Research Reports. 5, 4, p. 850-859 10 p.Research output: Contribution to journal › Original Article › peer-review
Open Access58 Citations (Web of Science) -
Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma
Feng, Z., Yuan, L., Ma, L., Yu, W., Kheir, F., Kaesmann, L., Brueckl, W. M. (Co-author), Jin, K., Wang, D., Shen, Y., Li, R. & Tian, H., 30 Jun 2024, In: TRANSLATIONAL LUNG CANCER RESEARCH. 13, 6, 20 p.Research output: Contribution to journal › Original Article › peer-review
Open Access
Prizes
-
Highlights vom amerikanischen Krebskongress
Ficker, J. H. (Chair), Brückl, W. (Organiser), Hoffmann, C. (Chair) & Brucker, C. (Organiser)
2 Jul 2022Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
36. InterPneu Nürnberg
Brückl, W. (Scientific member of the advisory board) & Ficker, J. H. (Organiser)
11 Oct 2019 → 12 Oct 2019Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
35. InterPneu Nürnberg
Ficker, J. H. (Organiser), Brückl, W. (Scientific member of the advisory board) & Neff, U. (Scientific member of the advisory board)
5 Oct 2018 → 6 Oct 2018Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
LANCET ONCOL (Journal)
Brückl, W. (Reviewer)
2018 → 2019Activity: Publication peer-review and editorial work › Publication Peer-review
-
34. InterPneu Nürnberg
Ficker, J. H. (Organiser), Brückl, W. (Scientific member of the advisory board) & Neff, U. (Scientific member of the advisory board)
6 Oct 2017 → 7 Oct 2017Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA